| Susie Tushingham, RN | |
|
23-00 R 208 S, Fairlawn, NJ 07410 | |
| (201) 625-1477 | |
| Not Available |
| Full Name | Susie Tushingham |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 23-00 R 208 S, Fairlawn, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871211961 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 26NR11243300 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susie Tushingham, RN 23-00 R208 S, Fairlawn, NJ 07410 Ph: () - | Susie Tushingham, RN 23-00 R 208 S, Fairlawn, NJ 07410 Ph: (201) 625-1477 |
News Archive
AlloSource, one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, has been named the Company of the Year by the Colorado BioScience Association. AlloSource is a repeat winner, having won this award in 2007.
Researchers from the University of Southampton have helped construct an online interactive world map which gives stark facts and figures about the health of women during pregnancy, childbirth and following the birth of their child.
Eighty designers, developers and medical experts from around the world will gather in Glasgow to solve the most pressing technology issues in medical education during AMEE Hacks, a 48-hour hackathon presented by the Association for Medical Education in Europe (AMEE).
The introduction of antiretroviral drugs in Botswana over the last two decades has increased the life expectancies of people living with HIV—many of whom are women co-infected with the human papillomavirus virus (HPV)—considerably: from 39 years to the low 60s. As a result, this co-infected group of women is at a much higher risk of developing HPV-associated cervical cancer.
› Verified 7 days ago